Skip to main content

Table 1 Inclusion and exclusion criteria

From: Rapid community point-of-care testing for COVID-19 (RAPTOR-C19): protocol for a platform diagnostic study

Inclusion criteria
 1. Adults (> 16 years)
  (a) Male or female
  (b) With suspected current or past COVID-19 (symptomatic SARS-CoV2 infection)
  (c) Having OP/NP swab for laboratory SARS-CoV2 RT-PCR as part of clinical care/testing
  (d) Willing and able to give informed consent for participation in the study
 2. Children (< 16 years old)
  (a) Male or female
  (b) With suspected current or past COVID-19 (symptomatic SARS-CoV2 infection)
  (c) Having OP/NP swab for laboratory SARS-CoV2 RT-PCR as part of clinical care/testing
  (d) Parent or legal guardian is willing and able to give informed consent for participation in the study
Exclusion criteria
 1. The participant may not enter the study if any of the following apply:
  (a) Adults unable to understand the study information and give consent to take part in the study
  (b) Need for immediate hospitalisation
  (c) Previously enrolled in this study in relation to the individual test being evaluated
  (d) Asymptomatic